Clinical Trials Browser

Terminated × Anemia, Aplastic × Methotrexate × Clear all

Anemia, Aplastic, Lymphoma, Follicular

NCT00720629 2014-07-18

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Primary Myelofibrosis

Clinical Trials

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation